Skip to main content

Table 1 Correlations of CD133 expression with clinicopathological parameters in the Stage IIIB colon carcinomas

From: Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Variables   gender age Invasive depth Sites of primary mass Grades Pathological classifications The percentage of CD133+ cells
gender P . .242 .541 .792 .129 .129 .785
age P .242 . .312 .075 .455 .869 .249
Invasive depth P .541 .312 . .895 .272 .426 .499
Sites of primary mass P .792 .075 .895 . .936 .022* .786
Grades P .129 .455 .272 .936 . .000** .536
Pathological classifications P .129 .869 .426 .022* .000** . .333
The percentage of CD133+ cells P .785 .249 .499 .786 .536 .333 .
  1. *: P < 0.05; **: P < 0.001